BIOLASE, Inc. (BIOLQ)

Market Cap	37.00 -100.0%
Revenue (ttm)	46.03M -7.4%
Net Income	-15.97M
EPS	-0.71
Shares Out	36.60M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	151
Average Volume	51,633
Open	0.0000
Previous Close	n/a
Day's Range	0.0000 - 0.0000
52-Week Range	0.0000 - 0.0200
Beta	-0.00
RSI	41.10
Earnings Date	n/a

About BIOLASE

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company provides Waterlase (all-tissue) systems for cutting soft and hard tissue; and diode (s...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1984
• Employees: 157
• Stock Exchange: OTCMKTS
• Ticker Symbol: BIOLQ

Financial Performance

In 2023, BIOLASE's revenue was $49.16 million, an increase of 1.45% compared to the previous year's $48.46 million. Losses were -$37.62 million, 30.4% more than in 2022.